Omics! Omics!

A computational biologist's personal views on new technologies & publications on genomics & proteomics and their impact on drug discovery

Friday, January 29, 2010

Whither science museums?

›
Last week at this time I was surviving a terrible electrical storm -- tremendous cracks and crackles all around me. Luckily, it was just th...
3 comments:
Thursday, January 28, 2010

A little more Scala

›
I can't believe how thrilled I was to get a run-time error today! Because that was the first sign I had gotten past the Scala roadblock...
1 comment:
Wednesday, January 27, 2010

The Scala Experiment

›
Well, I've taken the plunge -- yet another programming language. I've written before about this. It's also a common question on...
2 comments:
Thursday, January 21, 2010

A plethora of MRSA sequences

›
The Sanger Institute's paper in Science describing the sequencing of multiple MRSA (methicillin-resistant Staphylococcus aureus) genomes...
Wednesday, January 20, 2010

I'm definitely not volunteering for sample collection on this project

›
My post yesterday was successful at narrowing down the identity of the mystery creature to a spider of the genus Araneus. Another victory ...
1 comment:
Tuesday, January 19, 2010

Green Krittah

›
As a youth, I was fortunate enough to spend four summers working as a camp counselor. Three of those were spent in the Nature Department, p...
6 comments:
Tuesday, January 12, 2010

The Array Killers?

›
Illumina announced their new HiSeq 2000 instrument today. There are some great summaries at Genetic Future and PolitGenomics ; read both f...
2 comments:
Sunday, January 10, 2010

There's Plenty of Room at the Bottom

›
Friday's Wall Street Journal had a piece in the back opinion section (which has items about culture & religion and similar stuff) d...
Wednesday, January 06, 2010

On Being a Scientific Zebra

›
I got a phone call today from someone asking permission to suggest me as a reviewer of a manuscript this person was about to submit. For fu...
Monday, December 28, 2009

Length matters!

›
I was looking through part of my collection of papers using Illumina sequencing and discovered an unpleasant surprise: more than one does no...
2 comments:
Friday, December 18, 2009

Nano Anglerfish or Feejee Mermaids?

›
A few months ago I blogged enthusiastically about a paper in Science describing an approach to deorphan enzymes in parallel. Two anonymous...
Thursday, December 17, 2009

A Doublet of Solid Tumor Genomes

›
Nature this week published two papers describing the complete sequencing of a cancer cell line (small cell lung cancer (SCLC) NCI-H209 and m...
2 comments:
Monday, December 14, 2009

Panda Genome Published!

›
  Today's big genomics news is the advance publication in Nature of the giant panda (aka panda bear) genome sequence. For I'll be ...
Sunday, November 22, 2009

Targeted Sequencing Bags a Diagnosis

›
A nice complement to the one paper (Ng et al) I detailed last week is a paper that actually came out just before hand (Choi et al). Wherea...
1 comment:
Thursday, November 19, 2009

Three Blows Against the Tyranny of Expensive Experiments

›
Second generation sequencing is great, but one of it's major issues so far is that the cost of one experiment is quite steep. Just look...
1 comment:
‹
›
Home
View web version

About Me

My photo
Keith Robison
Dr. Robison spent 10 years at Millennium Pharmaceuticals working with various genomics & proteomics technologies & working on multiple teams attempting to apply these throughout the drug discovery process. He spent 2 years at Codon Devices working on a variety of protein & metabolic engineering projects as well as monitoring a high-throughput gene synthesis facility. After a brief bit of consulting, he rejoined the cancer drug discovery field at Infinity Pharmaceuticals in May 2009. In September 2011 he joined Warp Drive Bio, a startup applying genomics to natural product drug discovery. In February 2019 he joined Ginkgo Bioworks, a synthetic biology company. Other recurring characters in this blog are his late loyal Shih Tzu Amanda, his current Shih Poo Lily and his now adult son alias TNG (The Next Generation). Dr. Robison can be reached via his Gmail account, keith.e.robison@gmail.com You can also follow him on Twitter as @OmicsOmicsBlog.
View my complete profile
Powered by Blogger.